This inventor holds 1 USPTO granted patent. Top assignee: Idience Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Jeongeun Lee: Innovator in Pharmaceutical Composition
Introduction
Jeongeun Lee is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on poly (ADP-ribose) polymerase inhibitors. His research and inventions have the potential to impact the treatment of various diseases.
Latest Patents
Jeongeun Lee holds a patent for a pharmaceutical composition comprising phthalazinone derivatives. This invention relates to a stable pharmaceutical composition that demonstrates good activity as poly (ADP-ribose) polymerase inhibitors. The patent showcases his commitment to advancing medical science and improving therapeutic options.
Career Highlights
Jeongeun Lee is associated with Idience Co., Ltd., where he continues to develop and refine his innovative ideas. His work at the company reflects his dedication to research and development in the pharmaceutical industry. With 1 patent to his name, he is recognized for his contributions to the field.
Collaborations
Jeongeun Lee collaborates with talented individuals such as Jinhyuk Jeong and Daeun Jeon. These partnerships enhance the research environment and foster innovation within the company.
Conclusion
Jeongeun Lee is a prominent figure in the pharmaceutical industry, known for his innovative work on poly (ADP-ribose) polymerase inhibitors. His contributions are paving the way for advancements in medical treatments and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile